Investigative Urology - Results from #4420

An association between XPC Lys939Gln polymorphism and the risk of bladder cancer: a meta-analysis- Abstract March 20, 2013

Circulating microRNAs in serum: Novel biomarkers for patients with bladder cancer- Abstract March 20, 2013

Investigational cell cycle inhibitors in clinical trials for bladder cancer- Abstract March 20, 2013

Genetic variations in the transforming growth factor beta pathway as predictors of bladder cancer risk- Abstract March 20, 2013

Induction of apoptosis by sinulariolide from soft coral through mitochondrial-related and p38MAPK pathways on human bladder carcinoma cells- Abstract March 20, 2013

Determination of the differential expression of mitochondrial long non-coding RNAs as a noninvasive diagnosis of bladder cancer- Abstract March 20, 2013

Moving forward in bladder cancer detection and diagnosis: The role of epigenetic biomarkers- Abstract March 20, 2013

Study on bladder cancer susceptibility and genetic polymorphisms of XPC, XPG, and CYP in smokers and non-smokers- Abstract March 20, 2013

Conditionally ablated Pten in prostate basal cells promotes basal-to-luminal differentiation and causes invasive prostate cancer in mice- Abstract March 20, 2013

Upregulation of SATB1 is associated with prostate cancer aggressiveness and disease progression- Abstract March 20, 2013

Conditional deletion of the Pten gene in the mouse prostate induces prostatic intraepithelial neoplasms at early ages but a slow progression to prostate tumors- Abstract March 20, 2013

BMI1, stem cell factor acting as novel serum-biomarker for Caucasian and African-American prostate cancer- Abstract March 20, 2013

DAB2IP regulates autophagy in prostate cancer in response to combined treatment of radiation and a DNA-PKcs inhibitor- Abstract March 20, 2013

Interplay between genomic alterations and androgen receptor signaling during prostate cancer development and progression- Abstract March 20, 2013

Growth and progression of TRAMP prostate tumors in relationship to diet and obesity- Abstract March 20, 2013

Analysis of genetic aberrations on chromosomal region 8q21-24 identifies E2F5 as an oncogene with copy number gain in prostate cancer - Abstract March 20, 2013

Identification of cetrimonium bromide and irinotecan as compounds with synthetic lethality against NDRG1 deficient prostate cancer cells - Abstract March 20, 2013

Real-time individual predictions of prostate cancer recurrence using joint models - Abstract March 20, 2013

Local endocrine, paracrine and redox signaling networks impact estrogen and androgen crosstalk in the prostate cancer microenvironment - Abstract March 20, 2013

Differential signaling of the GnRH receptor in pituitary gonadotrope cell lines and prostate cancer cell lines - Abstract March 20, 2013

Page 222 of 346